Individual Tumor Profiling
Has Tumor Molecular Profiling Enabled More Effective and Less Toxic Cancer Treatment?
Top 10 Under 40
Up-and-Coming Stars Shine in Biopharma Research and Business
Podcast: FDA’s New Commissioner Hits the Ground Running
Scott Gottlieb, M.D., Commits to Speeding Up Drug Reviews, and Maintaining Safety and Efficacy
Liquid Biopsies Remain Wait and See for Some Clinicians
Circulating Biomarker Assays Promise to Refresh Cancer Profiling and Monitoring Practices
Many people have taken to going overseas to receive alternative “stem cell” treatments, some of which have not been approved in the U.S. Anecdotes abound in which patients are cured of diseases that defy conventional medicine by these treatments. But the field also has numerous patients who have not recovered—or whose deaths followed expensive procedures.